Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Watch and Wait in Advanced Stage, Asymptomatic Follicular Lymphoma
NCT00112931Phase 3Completed
- Sponsor
- University College London
- Start
- Sep 2004
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by University College London. Started Sep 2004; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00112931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112931.